Alphatec Holdings, Inc. 10-K

Item 5. Market for Registrant’s Common Equity, Related Sto ckholder Matters and Issuer Purchases of Equity Securities Market Information Our common stock is traded on The NASDAQ Global Select Market under the symbol “ATEC.” Stockholders As of February 19, 2025, there were approximately 425 holders of record of an aggregate 144,149,232 outstanding shares of our common stock. Dividend Policy We have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future. Unregistered Sales of Equity Securities and Use of Proceeds During the three months ended December 31, 2024, the Company issued unregistered equity securities as described below: Date Issued Number of Shares Grant Date Fair Value per Share (4) October 1, 2024 129,333 (1) $ 5.27 October 1, 2024 2,753 (2) $ 5.27 October 1, 2024 625 (3) $ 5.27 October 15, 2024 1,887 (2) $ 5.30 November 12, 2024 1,250 (3) $ 9.28 December 2, 2024 11,667 (1) $ 10.21 (1) Pursuant to Development Service Agreements for the development of products and intellectual property. (2) Consulting services rendered to the Company. (3) Independent sales agent services rendered to the Company. (4) Based on the market price of common stock on the issuance date. The issuances of the foregoing securities were made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, as there was no general solicitation and the transactions did not involve a public offering. Purchases of Equity Securities Under the terms of our 2016 Equity Incentive Plan and our Amended and Restated 2005 Employee, Director and Consultant Stock Plan, as amended, which we refer to collectively as the Stock Plans, and prior to the expiration of the Stock Plans in May 2026, we are permitted to award shares of restricted stock to our employees, directors, and consultants. These shares of restricted stock are subject to a lapsing right of repurchase by us. We may exercise this right of repurchase in the event that a restricted stock recipient’s employment, directorship or consulting relationship with us terminates prior to the end of the vesting period. If we exercise this right, we are required to repay the purchase price paid by or on behalf of the recipient for the repurchased restricted shares. Repurchased shares are returned to the Stock Plans and are available for future awards under the terms of the Stock Plans. There were no repurchases of common stock during the year ended December 31, 2024. 34 Table of Contents Stock Performance Graph The following graph compares the cumulative total stockholder return data on our common stock with the cumulative return of two indices: (i) The Nasdaq Stock Market Composite Index, and (ii) The Nasdaq Medical Equipment Index over the five-year period ending December 31, 2024. The graph assumes that $100 was invested on December 31, 2019 in our common stock and in each of the comparative indices, and the reinvestment of any dividends. The stock price performance on the following graph is not necessarily indicative of future stock price performance. The following graph and related information shall not be deemed "soliciting material" or deemed to be "filed" with the SEC, nor shall such information be incorporated by reference into any future filing, except to the extent that we specifically incorporate it by reference into such filing. COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN* AMONG ALPHATEC HOLDINGS, INC., THE NASDAQ COMPOSITE INDEX AND THE NASDAQ MEDICAL EQUIPMENT INDEX *$100 invested on December 31, 2019 in stock or index, including reinvestment of dividends. Item 6. Reserved 35 Table of Contents